Exploring pathophysiological phenotyping and medical optimization in secondary tricuspid valve regurgitation prior to tricuspid valve edge to edge repair

Back

HFA Premium Access

Exploring pathophysiological phenotyping and medical optimization in secondary tricuspid valve regurgitation prior to tricuspid valve edge to edge repair

Session: Valvular heart disease 2

Topic: Intervention

Speaker: Doctor I. Zarifis (London, GB)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ippokratis Zarifis

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Homozygous familial hypercholesterolemia surgical management and outcomes in up to 23 years follow up: a new Horizon for the Ross Procedure.

Speaker: Professor D. Galzerano (Riyadh, SA)

Insights into ultrasound-guided femoral puncture in transcatheter aortic valve replacement: analyzing vascular complications and mortality rates

Speaker: Doctor C. Gregorio (Lisbon, PT)

Prognostic implications of left atrial volume index in patients with ventricular functional mitral regurgitation underwent transcatheter edge-to-edge repair

Speaker: Doctor M. Maeda (Kumamoto, JP)

Impact of COAPT trial in patients with secondary mitral regurgitation submitted to MitraClip: an exploratory analysis of clinical outcomes in a tertiary care center

Speaker: Doctor F. Barbas De Albuquerque (Lisbon, PT)

Too little, too late: atrial secondary tricuspid regurgitation (A-STR) carries a better prognosis in early-stage heart failure, but not in late-stage

Speaker: Doctor C. Bourg (Rennes, FR)

Access the full session

Valvular heart disease 2

Speakers: Doctor I. Zarifis, Professor D. Galzerano, Doctor C. Gregorio, Doctor M. Maeda, Doctor F. Barbas De Albuquerque...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources